Trocars Market Size & Overview:

The Trocars Market was valued at USD 820.34 million in 2023 and is expected to reach USD 1464.88 million by 2032, growing at a CAGR of 6.70% from 2024 to 2032.

To Get more information on Trocars Market - Request Free Sample Report

The Trocars Market Report provides unique insights into volumes of surgical procedures, with regional differences in laparoscopic uptake in general, gynecological, and bariatric surgery. It presents trocar usage rates by application and region, with differences in device preference and penetration. The report also includes a detailed analysis of trocar sales volume trends, with a focus on changes fueled by technology and surgical innovation. It also provides a meticulous segmentation of the expenditure of healthcare on laparoscopic devices by payers—government, commercial, private, and out-of-pocket—providing an unparalleled view of budgetary expenditure and procurement practices in different healthcare systems.

Trocars Market Dynamics

Drivers

• The growing preference for minimally invasive surgeries (MIS) is a significant driver of the Trocars Market.

The increasing demand for minimally invasive surgeries (MIS) is a key growth driver for the Trocars Market. With patients and medical professionals looking for less recovery time, less postoperative pain, and less scarring, the need for laparoscopic and robotic-assisted surgeries is on the rise. As per the American Society of Anesthesiologists, more than 13 million laparoscopic procedures are carried out every year globally, with an increasing trend seen in gastrointestinal, gynecological, and urological procedures. Furthermore, technological innovation in trocar design, e.g., bladeless and optical trocars, has enhanced safety and efficiency, continuing to drive adoption. Recent advancements, including artificial intelligence-powered surgical robots and disposable trocars with reduced infection risks, have also driven market growth. Post-pandemic increases in elective surgeries, along with growing healthcare access in developing countries, continue to propel trocar demand worldwide.

• Increasing prevalence of chronic diseases requiring surgical intervention, accelerating the market to grow.

The increasing incidence of chronic diseases, including obesity, cancer, and gastrointestinal diseases, is largely increasing the demand for trocars. The World Health Organization (WHO) estimates that cancer cases are likely to increase by 47% worldwide by 2040, which in turn will raise diagnostic and therapeutic laparoscopic procedures. Correspondingly, an increased rate of gallbladder ailments and hernias has propelled a demand for minimally invasive procedures involving the use of trocars for careful instrument entry. For bariatric procedures that have witnessed an increase in demand by 20% over the last five years, trocars specifically designed to serve to ensure procedure efficacy and safety. New technologies, including antimicrobial-coated trocars to reduce infection rates and integration into robotic surgery systems, add to their embrace in contemporary surgical techniques.                                                                 

Restraint

• One of the major constraints in the Trocars Market is the exorbitant price tag of sophisticated trocar systems, especially those intended for robotic-assisted and minimally invasive procedures.

Disposable trocars, though minimizing infection rates, add to procedural costs, restricting their use in cost-conscious markets. Reusable trocars, however, need rigorous sterilization procedures to avoid cross-contamination, adding to operational costs for healthcare institutions. The estimates in the industry show that the costs of laparoscopic procedures may be 50% above that of traditional open procedures, due in part to the pricey disposable equipment necessary. Moreover, rigid regulatory expectations of surgical tool sterilization and patient protection only serve to increase the difficulty in deploying high-level trocars to large numbers. Developing countries mostly show this barrier through budget restrictions and limited accessibility of advanced laparoscopic instruments, thus suppressing growth in the market.

Opportunities

• The growing uptake of robot-assisted surgeries is a great opportunity for the trocars market.

With advances in minimally invasive surgical methods, robot-assisted procedures are gaining popularity because of their precision, minimal recovery time, and better patient results. Robot-assisted surgeries represented more than 15% of all minimally invasive surgeries in 2023, with consistent year-to-year growth, as per industry reports. There is increased demand for dedicated trocars compatible with robotic platforms, like bladeless and optical trocars, as surgical centers and hospitals acquire robotic platforms. There is increased concentration by firms in the design of trocars that have high maneuverability and minimal tissue damage to keep pace with robotic surgery demands. With the increasing use of robotic surgeries in general, gynecologic, and urologic surgeries, the use of technologically sophisticated trocars is likely to grow, stimulating market growth.

Challenges

• Navigating strict regulatory approval and compliance processes is one of the key issues in the trocars market.

Medical devices like trocars are required to conform to stringent safety and efficacy norms laid down by regulatory agencies like the U.S. FDA, the European Medicines Agency (EMA), and other global authorities. Such regulations involve lengthy clinical trials, quality control tests, and post-marketing surveillance, resulting in long approval periods and high compliance costs for manufacturers. For instance, in the U.S., FDA approvals for medical devices through the FDA's 510(k) clearance or Premarket Approval (PMA) process can last months to years, delaying product launches. Moreover, any non-compliance or recall issues can lead to financial penalties and reputational loss for manufacturers. Such regulatory barriers create a challenge for new players and small-scale firms, minimizing opportunities for innovation and market growth.

Trocars Market Segmentation Insights

By Product Type

The disposable trocars segment dominated the trocars market with a 62.86% market share in 2023 because of the increasing focus on infection control, regulatory requirements, and user-friendliness in surgical procedures. Healthcare centers, especially in developed parts of the world such as North America and Europe, value single-use surgical devices to reduce the risk of cross-contamination and adhere to strict sterilization protocols. Disposable trocars obviate the process of reprocessing and sterilization, minimizing hospital-associated infections (HAIs) and guaranteeing patient safety. Moreover, technological advancements in material technology have resulted in the creation of affordable, high-performance disposable trocars, which are now a favorite among ambulatory surgical centers and hospitals. The increasing number of laparoscopic procedures globally, coupled with positive reimbursement policies favoring minimally invasive procedures, further strengthened the market leadership of the segment in 2023.

The reusable trocars segment is witness to registering the fastest growth over the forecast years, driven by mounting cost-effectiveness measures and ecological concerns. As healthcare practitioners attempt to cut down on medical waste and long-term costs, reusable trocars adoption is increasing, especially in the developing world of Asia Pacific and Latin America. Advances in the technology of sterilization have enhanced the longevity and safety of reusable trocars, and thus, they are a true alternative to disposable trocars. Also, the increasing number of laparoscopic surgeries combined with the increased demand for environmentally friendly surgical solutions is compelling healthcare centers to invest in quality reusable trocars. With continued advancements in design and material toughness, reusable trocars should become a standard part of cost-cutting and eco-oriented surgical practice.

By Trocars Tip

The Bladeless Trocars segment dominated the market with around 45.32% market share in 2023 because of its better safety record, less tissue damage, and lower chance of vascular or organ injury while conducting laparoscopic surgeries. Unlike bladed trocars, the bladeless variants employ a blunt-tip mechanism to separate tissues rather than cut them, thereby avoiding postoperative complications and enhancing patient outcomes. The rising use of minimally invasive procedures (MIS) in general, gynecological, and bariatric surgeries has further driven the need for bladeless trocars due to their added precision with atraumatic access to the abdominal cavity. Furthermore, the improvements in trocar design, such as ergonomic elements and built-in sealing mechanisms, have further supported the use of bladeless over traditional options by surgeons, further driving their market leadership in 2023.

The Optical Trocars segment is expected to register the fastest growth over the forecast period based on the growing need for advanced visualization methods in laparoscopic procedures. The trocars are provided with a clear tip to hold an endoscope, through which real-time visualization of layers of tissue is possible, and exact entry into the abdominal cavity can be achieved. This aspect greatly diminishes the risks of complications such as accidental perforation of an organ, so optical trocars are a widely accepted option, particularly in demanding and risky surgeries. The increasing emphasis on safety for patients, advances in the technology of laparoscopic instruments, and more frequent robotic surgery are propelling the widespread usage of optical trocars. In addition, the increasing usage of these trocars in general, gynecological, and urology surgeries is predicted to drive the growth of the market for such trocars during the forecast years.

By Application

The General Surgery segment dominated the trocars market in 2023 and is expected to maintain its dominance with the fastest CAGR throughout the forecast period, on account of huge volumes of laparoscopic procedures being done for a multitude of conditions like hernia, cholecystectomy, appendectomy, and colorectal operations. The rapid incorporation of minimally invasive surgical (MIS) methods into general surgery has been a leading cause of escalating the demand for trocars because they are pivotal access ports for instruments used for laparoscopic purposes. In addition, the increase in gastrointestinal diseases, gallbladder illness, and obesity ailments has fueled the demand for laparoscopic procedures, promoting the market's growth further. Trocars with enhanced sealing and stability capabilities have become more favored by hospitals and surgical institutes for their enhanced procedural efficiency and patient benefits, which has also helped the segment hold the leading position in 2023.

Trocars Market Regional Analysis

North America dominated the trocars market with a 32.24% market share in 2023 because of the strong acceptance of minimally invasive procedures, sophisticated healthcare facilities, and the presence of major market players. The region has a well-developed regulatory environment, which makes high-quality surgical tools, including trocars, easily available. Furthermore, the growing incidence of conditions that necessitate laparoscopic surgeries, including gallbladder disorders, hernias, and gynecological conditions, has fueled the demand for trocars. The US, most notably, dominates the market owing to its high concentration of ambulatory surgery centers and hospitals that are equipped with sophisticated laparoscopic and robotic-assisted surgery technologies. Additionally, the availability of prominent market players such as Johnson & Johnson (Ethicon), Medtronic, and B. Braun has allowed for ongoing product innovations and new product launches, thus cementing North America's supremacy in the market.

Asia Pacific is the fastest-growing region for trocars with 7.79% CAGR, spurred by increasing healthcare expenditure, enhancing surgical infrastructure, and a growing patient pool needing minimally invasive procedures. China, India, and Japan are among the countries experiencing fast growth due to the increasing incidence of chronic diseases and government efforts in favor of advanced surgical procedures. The growing medical tourism industry in Thailand, South Korea, and India is also driving market growth as global patients are opting for low-cost but quality surgical procedures. Moreover, regional Asian Pacific manufacturers are also making affordable trocars, thus enabling laparoscopic surgeries to be more accessible. The increasing adoption of robotic surgeries, driven by rising hospital expenditure and foreign investments in healthcare technology, is further propelling the market's growth in this region.

Get Customized Report as per Your Business Requirement - Enquiry Now

Key Market Players

• Johnson & Johnson (Ethicon) (ENDOPATH XCEL Bladeless Trocar, ENDOPATH XCEL Optical Trocar)

• Medtronic (VersaOne Bladeless Trocar, Visiport Plus Optical Trocar)

• B. Braun (BLAKE Silicone Drains, Aesculap Access Ports)

• Applied Medical (Kii Fios First Entry Trocar, Kii Balloon Blunt Tip System)

• Conmed Corporation (AirSeal Access Port, DetachaTip Reusable Trocar System)

• Teleflex Incorporated (Weck EFx Endo Fascial Closure System, MiniLap Percutaneous Surgical System)

• CooperSurgical (SeeClear Smoke Evacuation System, RUMI II Uterine Manipulator)

• Geyi Medical Instrument (Disposable Bladeless Trocar, Disposable Bladed Trocar)

• Hangzhou Kangji Medical Instruments (Disposable Laparoscopic Trocar, Disposable Optical Trocar)

• Purple Surgical (Universal Seal Laparoscopic Trocar, Optical Tip Trocar)

• Genicon (Single Use Bladeless Trocar, Single Use Optical Trocar)

• Laparosurge (LS Optical Trocar, LS Bladeless Trocar)

• Seemann Technologies (Disposable Laparoscopic Trocar, Reusable Laparoscopic Trocar)

• Victor Medical Instruments (Disposable Bladeless Trocar, Disposable Optical Trocar)

• Bluesail Surgical (Disposable Laparoscopic Trocar, Disposable Optical Trocar)

• SurgiCore (Disposable Bladeless Trocar, Disposable Optical Trocar)

• Surgsci Medical (Disposable Laparoscopic Trocar, Disposable Optical Trocar)

• Unimax Medical Systems (Disposable Bladeless Trocar, Disposable Optical Trocar)

• VECTEC (Disposable Laparoscopic Trocar, Disposable Optical Trocar)

• Zhejiang Geyi Medical Instrument (Disposable Bladeless Trocar, Disposable Bladed Trocar)

Suppliers (These key suppliers provide essential components, raw materials, and precision-engineered parts used in the manufacturing of trocars, including medical-grade plastics, stainless steel, seals, and tubing. They also offer contract manufacturing, OEM solutions, and customization services to support trocar design, assembly, and performance enhancement.) in Trocars Market

• Nordson Medical

• Bal Seal Engineering, Inc.

• Freudenberg Medical

• Spectrum Plastics Group

• Teleflex Medical OEM

• Qosina Corporation

• Merit Medical Systems

• Minnetronix Medical

• Cadence Inc.

• Medbio LLC

Recent Development:

• November 2024: Johnson & Johnson MedTech achieved Investigational Device Exemption (IDE) from the U.S. FDA for its OTTAVA robot-assisted surgical system, making it possible to start clinical trials in the United States. The OTTAVA system has a novel architecture that includes four low-profile robotic arms mounted on the operating table to provide greater flexibility in multiple surgeries.

• January 2025: Medtronic named Thierry Pieton, previously Renault's finance director, as its new Chief Financial Officer, starting March 3. Pieton's tenure at Renault saw impressive sales growth, setting him up to make contributions to Medtronic's financial operations and strategies.

• July 2024: B. Braun introduced the Aesculap EinsteinVision 3.0, a sophisticated 3D laparoscopy imaging system intended to increase surgical accuracy and ergonomics. The system provides enhanced depth perception and image quality that aids minimally invasive surgical treatments.